|
2025 Conference Publication Exploring PD1/PDL1 interactions and macrophage-tumor barriers in head and neck cancer: A spatial approach to immunotherapy responseNaei, Vahid Yaghoubi, Tubelleza, Rafael, Monkman, James, Sadeghirad, Habib, Donovan, Meg L., Blick, Tony, Wicher, Agata, Bodbin, Sara, Basu, Subham, Stad, Robert, Barnett, Catherine, O’Byrne, Ken, Ladwa, Rahul, Cooper, Caroline, Warkiani, Majid Ebrahimi, Hughes, Brett G.M. and Kulasinghe, Arutha (2025). Exploring PD1/PDL1 interactions and macrophage-tumor barriers in head and neck cancer: A spatial approach to immunotherapy response. AACR Annual Meeting 2025, Chicago, IL United States, 25-30 April 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2025-750 |
|
2025 Conference Publication Recommendations for molecular testing of lung cancer in Australia: consensus guidelines from the Royal College of Pathologists of Australasia and the Thoracic Oncology Group of AustralasiaCooper, Wendy A., Amanuel, Benhur, Cooper, Caroline, Fox, Stephen B., Graftdyk, Jon W.A., Jessup, Peter, Klebe, Sonja, Lam, Wei-Sen, Y-M. Leong, Trishe, Lwin, Zarnie, Roberts-Thomson, Rachel, Solomon, Benjamin J., Tay, Rebecca Y., Wale, Janney L. and Pavlakis, Nick (2025). Recommendations for molecular testing of lung cancer in Australia: consensus guidelines from the Royal College of Pathologists of Australasia and the Thoracic Oncology Group of Australasia. Pathology Update 2025, Melbourne, VIC Australia, 21-23 February 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2024.12.013 |
|
2024 Conference Publication Alterations In Local Oesophageal Microbiota And Outcomes After Oesophagectomy For Oesophago-gastric Cancer: A Pilot StudyStokes, Matthew, (Frank) Yu, Zirong, Schlebusch, Sanmarie, Jennison, Amy, Graham, Rikki, Cooper, Caroline, Smithers, B. Mark, Barbour, Andrew, Thomson, Iain and Frankel, Adam (2024). Alterations In Local Oesophageal Microbiota And Outcomes After Oesophagectomy For Oesophago-gastric Cancer: A Pilot Study. 20th ISDE World Congress for Esophageal Diseases, Edinburgh, United Kingdom, 22 - 24 September 2024. Cary, NC United States: Oxford University Press. doi: 10.1093/dote/doae057.006 |
|
2024 Conference Publication A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma (cSCC) with the use of neoadjuvant pembrolizumab: De-SquamateLadwa, Rahul, Lee, Jenny H.J., Porceddu, Sandro V., McGrath, Margaret Louise, Cooper, Caroline, Liu, Howard, Gupta, Ruta, Cuscaden, Claire, Nottage, Michelle K., Clark, Jonathan, Le, Dieu, Pauley, Marketa, Gonzalez-Cruz, Jazmina, Frazer, Ian, Hughes, Brett Gordon Maxwell and Panizza, Benedict J. (2024). A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma (cSCC) with the use of neoadjuvant pembrolizumab: De-Squamate. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.9514 |
|
2024 Conference Publication Spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma revealed immune cell type infiltration into the TME as a predictor of immunotherapy responseSadeghirad, Habib, Tan, Chin Wee, Liu, Ning, Monkman, James, Cooper, Caroline, O’Byrne, Ken, Davis, Melissa, Hughes, Brett and Kulasinghe, Arutha (2024). Spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma revealed immune cell type infiltration into the TME as a predictor of immunotherapy response. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-1154 |
|
2023 Conference Publication EP06.02-01 Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian PerspectivePrabhakaran, S., Russell, P.A., Farrall, A.L., Asadi, K., Barrett, W., Cooper, C., Cooper, W., Duhig, E.E., Egan, M., Fox, S., Godbolt, D., Gupta, S., Cotton, S., Leslie, C., Leong, T., Moffat, D., Qiu, M., Sivasubramaniam, V., Snell, C., Skerman, J., Walsh, M., Whale, K. and Klebe, S. (2023). EP06.02-01 Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian Perspective. 2023 World Conference on Lung Cancer, Singapore, 9-12 September 2023. New York, NY United States: Elsevier. doi: 10.1016/j.jtho.2023.09.886 |
|
2023 Conference Publication High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC studyLadwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278 |
|
2022 Conference Publication High-plex spatial proteomic profiling of immunotherapy response groups in head and neck cancer identifies tissue signatures associated with therapy responseKulasinghe, Arutha, Sadeghirad, Habib, Liu, Ning, Monkman, James, Tan, Chin Wee, Cooper, Caroline, Church, Sarah, Schneider, Fabian, Thaagard, Jeppe, Mansfield, James, O’byrne, Kenneth, Davis, Melissa and Hughes, Brett (2022). High-plex spatial proteomic profiling of immunotherapy response groups in head and neck cancer identifies tissue signatures associated with therapy response. SITC 37th Annual Meeting (SITC 2022), Boston, MA United States, 8–12 November 2022. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2022-sitc2022.0117 |
